Apply to speak to attorney Dave Fournier about issues that early stage life-science companies face, from basics like identifying potentially patentable subject matter to filing strategies and conducting diligence.
Scroll down to apply for a 45-minute Zoom timeslot with David Fournier, David Fournier, firmwide Patent Prosecution & Portfolio Counseling practice chair, at Perkins Coie, on the morning of Thursday, November 3.
David Fournier, firmwide Patent Prosecution & Portfolio Counseling practice chair, is an intellectual property partner with 20 years of life sciences experience. Prior to becoming an attorney, Dave spent several years working in clinical research and as a patent agent with Pfizer and its legacy companies, where he was responsible for monitoring drug trials and the development and implementation of product lifecycle management strategies for a variety of key products. Through that industry experience, Dave gained valuable insight into drug development and product lifecycle management strategies.
Dave’s practice concentrates on pharmaceutical, biologic, medical device and consumer product patent matters, with particular emphasis on product exclusivity planning, strategic development of global patent portfolios and client counseling under the Drug Price Competition and Patent Term Restoration (Hatch-Waxman) Act, relating to pharmaceutical products, and the Public Health Service Act and the Biologics Price Competition and Innovation Act, relating to biologic therapies.
Our Expert Consults are hosted by leading experts who have generously offered their services pro bono to our entrepreneurs.
If selected for an appointment, please be punctual; arrivals late by more than 15 minutes will be considered no-shows.